Lannett Company recalls 5mg extended-release dextroamphetamine capsules due to labeling error. Capsules contain only immediate-release pellets but are labeled as extended-release. No immediate action needed but check labels carefully.
“Dextroamphetamine Extended-Release Capsules: Label Mix-Up Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/31175-dextroamphetamine-extended-release-capsules-label-mix-up-risk. Based on FDA recall #D-0660-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0660-2026%22&limit=1).
The FDA announced on June 26, 2026, that Lannett Company Inc. is recalling Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules due to a labeling mix-up. The hazard involves capsules containing only immediate-release pellets while being labeled as extended-release. Owners should contact the company for a remedy.
The capsules contain only immediate-release (IR) pellets while labeled as ER capsules, according to the FDA. This labeling error constitutes a Class II recall.
Context
GovInfoNow's records show Lannett Company Inc. has 13 other recalls on record since October 11, 2018. Other recent recalls of similar products include Lannett Niacin Extended-release Tablets Recall (May 27, 2026), Lannett Primidone Tablets Recall (April 24, 2026), and Lannett Niacin Extended-release Tablets Recall (October 10, 2025). Other recent recalls of similar products include Supernus Trokendi XR 25mg Capsules (July 6, 2026), Supernus Trokendi XR 50mg Capsules (August 31, 2026), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026).
How to tell if you have this one
Check for the label that says 'Extended-Release' but the capsules contain only immediate-release pellets. The product is 5mg, 100 capsules, with NDC number 0527-0790-37.
Brand
Lann: A short, human brand name for headings (e.g.
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Label Carefully
Look for the label that says 'Extended-Release' but the capsules contain only immediate-release pellets.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 12 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0660-2026 (June 26, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0660-2026 to see it in context.
Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.